• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up
  • Login

Select Page
Advertisement

PRIME January/February 2025

Digital Magazine, News

Share:

PreviousMerz Aesthetics Reveals Global Data on the Connection Between Confidence, Self-Affirmation and Aesthetic Treatments
NextEvolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels

Related Posts

Reconstructive Surgery Trips to Developing Countries Are Cost-Effective and Sustainable

Reconstructive Surgery Trips to Developing Countries Are Cost-Effective and Sustainable

September 6, 2019

UTMB develops promising anti-obesity drug that shrinks fat without suppressing appetite

UTMB develops promising anti-obesity drug that shrinks fat without suppressing appetite

January 15, 2018

What is Kolkhida?

What is Kolkhida?

February 28, 2018

New Study Confirms Physicians Perform the Majority of Cosmetic Injections

New Study Confirms Physicians Perform the Majority of Cosmetic Injections

August 4, 2021

Search

Login Status

Forgot?  Register

May/June 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy